Topics

Cognate BioServices Company Profile

06:01 EDT 20th September 2019 | BioPortfolio

Cognate BioServices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development and manufacture of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.


News Articles [58 Associated News Articles listed on BioPortfolio]

Cellular therapy CDMO Cognate closes growth capital round

Cognate BioServices closes a round of growth capital from EW Healthcare Partners to secure its capabilities for the commercialization of advanced cellular therapies.

Caladrius Biosciences and Cognate BioServices Establish Manufacturing Agreement for Phase 3 Confirmatory Pivotal Clinical Trial of CLBS14 in No-option Refractory Disabling Angina

BASKING RIDGE, N.J. and MEMPHIS, Tenn., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development bi...

Catalent to buy CDMO Paragon Bioservices for $1.2bn

Paragon Bioservices is a major viral vector development and manufacturing partner for gene therapies. Paragon president and CEO Pete Buzy said: “We are excited to join forces with The post Catalent...

Catalent closes $1.2bn acquisition of Paragon Bioservices

Catalent has closed an acquisition of viral vector development and gene therapy manufacturing company Paragon Bioservices for $1.2bn. Having signed an...Read More... The post Catalent closes $1.2bn a...

Masy BioServices Acquires Metrology Laboratories

MLI will now be known as Masy BioServices and will continue to work from the current office

US Bioservices to exclusively dispense Diacomit

Catalent acquires CDMO Paragon Bioservices for $1.2bn

Catalent Inc. acquired private US biologics CDMO Paragon Bioservices Inc., a developer of viral vectors and manufacturer of gene therapies.

Catalent to buy Paragon Bioservices for $1.2 billion: WSJ

Drug developer Catalent Inc has agreed to buy privately held Paragon Bioservices Inc for $1.2 billion, the Wall Street Journal reported on Sunday, citing people familiar with the matter.

Drugs and Medications [0 Results]

None

PubMed Articles [44 Associated PubMed Articles listed on BioPortfolio]

Novel parameter describing restriction endonucleases: Secondary-Cognate-Specificity and chemical stimulation of TsoI leading to substrate specificity change.

Over 470 prototype Type II restriction endonucleases (REases) are currently known. Most recognise specific DNA sequences 4-8 bp long, with very few exceptions cleaving DNA more frequently. TsoI is a ...

More Pieces of Ancient than Recent Theoretical Minimal Proto-tRNA-Like RNA Rings in Genes Coding for tRNA Synthetases.

Theoretical minimal RNA rings were designed to mimick life's primordial RNAs by forming stem-loop hairpins and coding once for each of the 20 amino acids, a start and a stop codon. At most 25 22-nucle...

Binding of a Naja naja venom acidic phospholipase A cognate complex to membrane-bound vimentin of rat L6 cells: Implications in cobra venom-induced cytotoxicity.

An acidic phospholipase A enzyme (NnPLA-I) interacts with three finger toxins (cytotoxin and neurotoxin) from Naja naja venom to form cognate complexes to enhance its cytotoxicity towards rat L6 myoge...

Specific detection of avian influenza H5N2 whole virus particles on lateral flow strips using a pair of sandwich-type aptamers.

We report a selection of a cognate pair of aptamers for whole avian influenza virus particles of H5N2 by using graphene-oxide based systemic evolution of ligands by exponential enrichment (GO-SELEX), ...

Lexical and syntactic target language interactions in translation.

The aim of the study was to evaluate the possible interaction between syntactic and lexical properties of the target language (TL) in consecutive translation. To this end, participants read sentences ...

Clinical Trials [7 Associated Clinical Trials listed on BioPortfolio]

Common Sensing and Right Ventricular Automatic Capture (COGNATE)

This study will collect data on features for future pacemakers via an external non-implantable system.

Cochlear Implant Speech and Non-speech Sound Recognition

The primary purpose of the research is to study how synthesized speech and non-speech percepts (sounds) are recognized in subjects with cochlear implants (CI) who are not getting functiona...

A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation

Hepatocellular carcinoma (HCC) represent approximately 70-85% of liver cancer, in which Hepatitis B virus (HBV) is the major etiologic agent accounting for at least 80% of HCC in Asian cou...

Cognate Patient Care Insight Scale

Schizophrenia is a disease of young adults that affects 1% of the general population. According to numerous studies, it has been estimated that between 50% and 80% of patients with schizop...

DNA Methylation in Allogeneic Hematopoietic Stem Cell Transplantation.

As a consequence of the impending increase in life expectancy, there is urgent need to adopt life-saving interventions, such as hematopoietic stem cell transplantation, (SCT) in groups of ...

Companies [15 Associated Companies listed on BioPortfolio]

Cognate BioServices

Cognate BioServices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development a...

Paragon Bioservices Incorporated

Paragon Bioservices apply focused capabilities to client needs throughout each stage of discovery and preclinical development. Current areas of active involvement include:Aging, Angiogenesis, Infectio...

Kaimalil Bioservices

We are fast growing Bioservices company. Our expertises are in the domains of Clinical Research, Medical Writing, Knowledge Processing, Technology and Consulting Services. We have 33 years of experie...

Paragon Bioservices, Inc.

Paragon Bioservices (www.paragonbioservices.com) offers contract services for accelerating the development and manufacturing of biologics. Highly flexible and responsive, we work in partnership with o...

Molecular Medicine LLC

The mission of Molecular Medicine BioServices, Inc. is to assist clients in initiating their clinical research projects through development and production of viral vectors and vaccines, master cell an...

More Information about "Cognate BioServices" on BioPortfolio

We have published hundreds of Cognate BioServices news stories on BioPortfolio along with dozens of Cognate BioServices Clinical Trials and PubMed Articles about Cognate BioServices for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cognate BioServices Companies in our database. You can also find out about relevant Cognate BioServices Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record